Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
12 12 Search
2024
Identifying Optimal Candidates for Primary Tumor Resection Among Metastatic Pancreatic Cancer Patients: A Population-Based Predictive Model
Cancer Investigation
2024
Association between chronic pancreatitis and pancreatic cancer at a central hospital in KwaZulu-Natal, South Africa
South African Journal of Surgery
2022
Women with Abnormal Mammographic Findings and High Neutrophil-to-Lymphocyte Ratio have the Worst Dietary Carbohydrate Quality Index
Nutrition and Cancer
2022
Radiomics Combined with Multiple Machine Learning Algorithms in Differentiating Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor: More Hands Produce a Stronger Flame
Journal of Clinical Medicine
2021
Reduction of gender‐associated M2‐like tumor‐associated macrophages in the tumor microenvironment of patients with pancreatic cancer after neoadjuvant chemoradiotherapy
Journal of Hepato-Biliary-Pancreatic Sciences
2021
High Expression of PD-L1 Is Associated with Better Survival in Pancreatic/Periampullary Cancers and Correlates with Epithelial to Mesenchymal Transition
Diagnostics
2021
Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy
Clinical Medicine Insights: Oncology
2021
Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china
Expert Review of Pharmacoeconomics & Outcomes Research
2020
Pancreatic Adenocarcinoma in Patients with Type 2 Diabetes: Prognosis and Survival
Cureus
2020
Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
BMC Cancer
2020
<p>Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer</p>
Cancer Management and Research
2019
MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12
Journal of Experimental & Clinical Cancer Research